Abstract
Myasthenia Gravis (M.G.) is an autoimmune disease with antibodies directed against the skeletal muscle acetylcholine receptor (AChR) (4). Although the production of AChR antibodies is due to B lymphocytes, there is evidence that T cells are involved in the autoantibody response. (4, 18).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beghi E, Antozzi C, Batocchi AP, Cornelio F, Cosi V, Evoli A, Lombardi M, Mantegazza R, Monticelli M L, Piccolo G, Tonali P, Trevisan D, Zarrelli M. 1991. Prognosis of Myasthenia gravis: a multicenter followup study of 844 patients. J Neurol Sci. 106:213–220.
Blalock A, Mason MF, Morgan HJ, Raven SS. 1939. Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed. Ann Surg.l 10:544–561.
Castleman B. 1966. The pathology of the thymus gland in Myasthenia Gravis. Ann N Y Acad Sci. 135:496–505.
Drachman D B. 1994. Myasthenia Gravis. N Engl J Med. 330:1797–1810.
Durelli L, Maggi G, Casadio C, Ferri R, Rendine S, Bergamini L. 1991. Actuarial analysis of the occurrence of remissions following thymectomy for Myasthenia Gravis in 400 patients. J Neurol Neurosurg Psych. 54:406–411.
Hassel B, Gilhus NE, Aarli JA, Skogen OR. 1992. Fulminant Myasthenia Gravis and polymyositis after thymectomy for thymoma. 85:63–65.
Holfeld R.1980. Myasthenia Gravis and thymoma: paraneoplastic failure of neuromuscular transmission. Lab Invest. 62:241–243.
Kuroda Y, Ken-ichiro O, Neshige R, Shibasaki H. 1993. Exacerbation of Myasthenia Gravis after removal of a thymoma having a membrane phenotype of suppressor T cells. Ann Neurol. 15:400–402.
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. 1991. Thymoma: results of 241 operated cases. Ann Thorac Surg 51:152–156.
Muller-Hermelink HK, Marx A, Gender K, Kirchner T. 1993. The pathological basis of thymoma-associated Myasthenia Gravis. Ann N Y Acad Sci. 681:56–65.
Namba T, Brunner NG, Grob D. 1978. Myasthenia Gravis in patients with thymoma with particular reference to onset after thymectomy. Medicine. 57:411–432.
Neau P, Robert R, Pourrat O, Patte F, Gil R, Lefevre J P. 1988. Myasthenic survenant après ablation d’un thymome. La Presse Med. 17:391–392.
Osserman K E, Genkins G. 1971. Studies in Myasthenia Gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 38:497–537.
Palmisani MT, Evoli A, Batocchi AP, Provenzano C, Tonali P. 1993. Myasthenia Gravis associated with thymoma: clinical characteristic and long term outcome. Eur Neurol. 34:78–82.
Papatestas AE, Genkins G, Kornfeld P, Eisenkraft JB, Fagerstrom RP, Pozner J, Aufses A. H. 1987. Effects of thymectomy in Myasthenia Gravis. Ann Surg. 206:79–88.
Sommer N, Willcox N, Harcourt GC, Newsom-Davis J. 1990 Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol. 28:312–319.
Somnier F E. 1994. Exacerbation of Myasthenia Gravis after removal of thymomas. Acta Neurol Scand. 90:56–66.
Wekerle H. 1993. The Thymus in Myasthenia Gravis. Ann N Y Acad Sci. 681:47–55.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tezzon, F., Passarin, M.G., Zanoni, T., Furlan, G., Ferrari, G. (1997). Onset of Myasthenia Gravis after Thymectomy for Thymoma. In: Marx, A., Müller-Hermelink, H.K. (eds) Epithelial Tumors of the Thymus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0033-3_42
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0033-3_42
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0035-7
Online ISBN: 978-1-4899-0033-3
eBook Packages: Springer Book Archive